CK Life Sciences International (Holdings), Inc. (775) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd.

Zhongzhi Pharmaceutical Holdings Ltd.

China Shineway Pharmaceutical Group Ltd.

Shandong Xinhua Pharmaceutical Co., Ltd.

Sihuan Pharmaceutical Holdings Group Ltd.

HBM Holdings Ltd.

CK Life Sciences International (Holdings), Inc.

Wai Yuen Tong Medicine Holdings Ltd.

PuraPharm Corp. Ltd.

Hin Sang Group (International) Holding Co. Ltd.

China Health Group, Inc.

Why is CK Life Sciences International (Holdings), Inc. ?

Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months

High Debt Company with a Debt to Equity ratio (avg) at times

Negative results in Jun 25

OPERATING CASH FLOW(Y) Lowest at HKD 199.43 MM
ROCE(HY) Lowest at -7.26%
PRE-TAX PROFIT(Q) Lowest at HKD -135.23 MM

With ROE of 1.27%, it has a Very Expensive valuation with a 2.45 Price to Book Value

Over the past year, while the stock has generated a return of 95.35%, its profits have fallen by -60.1%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is CK Life Sciences International (Holdings), Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

CK Life Sciences International (Holdings), Inc.

97.65%

2.19

59.42%

Hang Seng Hong Kong

27.36%

1.03

25.88%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

381.57%

EBIT Growth (5y)

69.38%

EBIT to Interest (avg)

0.24

Debt to EBITDA (avg)

2.62

Net Debt to Equity (avg)

1.42

Sales to Capital Employed (avg)

0.26

Tax Ratio

100.00%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

0.51%

ROE (avg)

1.31%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

192

Industry P/E

Price to Book Value

2.45

EV to EBIT

1089.29

EV to EBITDA

162.82

EV to Capital Employed

1.60

EV to Sales

5.44

PEG Ratio

Dividend Yield

ROCE (Latest)

0.15%

ROE (Latest)

1.27%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

CASH AND EQV(HY)

Highest at HKD 797.84 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 6.33%

-16What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at HKD 199.43 MM

ROCE(HY)

Lowest at -7.26%

PRE-TAX PROFIT(Q)

Lowest at HKD -135.23 MM

NET PROFIT(Q)

Lowest at HKD -150.74 MM

RAW MATERIAL COST(Y)

Grown by 9.65% (YoY

EPS(Q)

Lowest at HKD -0.02

Here's what is working for CK Life Sciences International (Holdings), Inc.

Cash and Eqv

Highest at HKD 797.84 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio

Highest at 6.33%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for CK Life Sciences International (Holdings), Inc.

Pre-Tax Profit

At HKD -135.23 MM has Fallen at -3,660.66%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (HKD MM)

Net Profit

At HKD -150.74 MM has Fallen at -18,536.97%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (HKD MM)

Pre-Tax Profit

Lowest at HKD -135.23 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (HKD MM)

Net Profit

Lowest at HKD -150.74 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (HKD MM)

Operating Cash Flow

Lowest at HKD 199.43 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

EPS

Lowest at HKD -0.02

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (HKD)

Raw Material Cost

Grown by 9.65% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales